Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques

Heart

Volumn 76, Issue 4, 1996, Pages 312-316

  Van Der Wal, Allard C ^a   Becker, Anton E ^a,b   Koch, Karel T ^a   Piek, Jan J ^a   Teeling, Peter ^a   Van Der Loos, Chris M ^a   David, George K ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Coronary atherosclerosis; Immunohistochemistry; Inflammation; Ischaemic coronary; Syndromes

Indexed keywords

ANGINA PECTORIS; ARTICLE; ATHEROSCLEROSIS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; INFLAMMATION; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; T LYMPHOCYTE;

EID: 0029913937     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.76.4.312     Document Type: Article

References (27)

1. Fuster V, Badimon L, Badimon J, Chesebro JH. Mechanisms of disease. I. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
2. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:363-73.
3. Richardson PD, Davies MJ, Bom GVR. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989;2: 941-4.
4. Falk E. Why do plaques rupture? Circulation 1992;86:III-30-42.
5. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993;69:377-81.
6. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. Circulation 1993;87: 1179-87.
7. Loree HM, Kamm RD, Stringfellow RG, Lee RT. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Cire Res 1992;71:850-8.
8. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994;90:775-8.
9. Arbustini E, De Servi S, Bramucci E, Porcu E, Constante AM, Grasso M, et al. Comparison of coronary lesions obtained by directional atherectomy in unstable angina, stable angina and restenosis after either atherectomy or angioplasty. Am J Cardiol 1995;75:675-82.
10. Van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimai rupture or erosion of thiombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
11. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994;331:468-9.
12. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-503.
13. Kaski JC, Chester MR, Chen L, Katritsis D. Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology. Circulation 1995;92:2058-65.
14. Hangartner JRW, Charleston AJ, Davies MJ, Thomas AC. Morphological characteristics of clinically significant coronary artery stenosis in stable angina. Br Heart J 1986;56:501-8.
15. Campeau L. Grading of angina pectoris. Circulation 1976; 54:522-3.
16. Braunwald E. Unstable angina: a classification. Circulation 1989;80:410-4.
17. Van der Loos CM, Das PK, van den Oord JJ, Houthof H-J. Multiple immunoenzyme staining techniques. Use of fluoresceinated biotinylated and unlabeled monoclonal antibodies. J Immunol Methods 1989;117:45-52.
18. Hansson GK, Jonasson L, Seifert P, Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis 1989;9: 567-78.
19. Van der Wal AC, Das PK, Bentz-van den Berg D, van der Loos CM, Becker AE. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 1989;61:166-70.
20. Galis Z, Sukhova G, Kranzhöfer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix degrading proteinases. Proc Natl Acad Sci USA 1995;92:402-6.
21. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry T, Murphy G, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 1991;88:8154-8.
22. Brown DL, Hibbs MS, Keamey M, Loushin C, Isner JM. Identification of 92 kD gelatinase in human coronary atherosclerotic lesions. Circulation 1995;91:2125-31.
23. Stemme S, Faber B, Holm J, Wiklund O, Witzum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995;92:3893-7.
24. Brown BG, Zhao X-Q, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993;87:1781-91.
25. Jukema JW, Bruschke AVG, van Boven AJ, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: the Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995;91:2528-10.
26. Libby P. Molecular basis of the acute coronary syndromes. Circulation 1995;91:2844-50.
27. Davies MJ, Bland JM, Hangartner JRW, Angelini A, Thomas AC. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. Eur Heart J 1989;10:203-8.